{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:37:05Z","timestamp":1793723825513,"version":"4.6.1"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T00:00:00Z","timestamp":1529366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"AstraZeneca Spain S.A."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Health Econ"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s10198-018-0986-y","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T11:33:57Z","timestamp":1529408037000},"page":"135-147","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["The economic burden of disease of epithelial ovarian cancer in Spain: the OvarCost study"],"prefix":"10.1007","volume":"20","author":[{"given":"Laura","family":"Delgado-Ortega","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almudena","family":"Gonz\u00e1lez-Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep Mar\u00eda","family":"Borr\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Oliva-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Gonz\u00e1lez-Haba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salom\u00f3n","family":"Menj\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Vicente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Cordero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Sim\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Hidalgo-Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlota","family":"Moya-Alarc\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,19]]},"reference":[{"key":"986_CR1","unstructured":"Ferlay, J., Soerjomataram, I., Ervik, M., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D., Forman, D., Bray, F.: Globocan 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11, \n                    http:\/\/globocan.iarc.fr\/Default.aspx"},{"key":"986_CR2","unstructured":"World Health Organization (WHO): EUCAN Factsheets|Ovarian cancer, \n                    http:\/\/eco.iarc.fr\/eucan\/CancerOne.aspx?Cancer=27&Gender=2#block-mapc-f"},{"key":"986_CR3","doi-asserted-by":"publisher","first-page":"vi24","DOI":"10.1093\/annonc\/mdt333","volume":"24","author":"JA Ledermann","year":"2013","unstructured":"Ledermann, J.A., Raja, F.A., Fotopoulou, C., Gonzalez-Martin, A., Colombo, N., Sessa, C.: Group, on behalf of the E.G.W.: Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 24, vi24\u2013vi32 (2013). \n                    https:\/\/doi.org\/10.1093\/annonc\/mdt333","journal-title":"Ann. Oncol."},{"key":"986_CR4","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1007\/s12094-015-1435-3","volume":"17","author":"G Llort","year":"2015","unstructured":"Llort, G., Chirivella, I., Morales, R., Serrano, R., Sanchez, A.B., Teul\u00e9, A., Lastra, E., Brunet, J., Balma\u00f1a, J., Gra\u00f1a, B.: Group, O. behalf of the S.H.C.W.: SEOM clinical guidelines in hereditary breast and ovarian cancer. Clin. Transl. Oncol. 17, 956 (2015). \n                    https:\/\/doi.org\/10.1007\/s12094-015-1435-3","journal-title":"Clin. Transl. Oncol."},{"key":"986_CR5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3322\/caac.20113","volume":"61","author":"D Jelovac","year":"2011","unstructured":"Jelovac, D., Armstrong, D.K.: Recent progress in the diagnosis and treatment of ovarian cancer. CA Cancer J. Clin. 61, 183\u2013203 (2011). \n                    https:\/\/doi.org\/10.3322\/caac.20113","journal-title":"CA Cancer J. Clin."},{"key":"986_CR6","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/S0140-6736(09)61338-6","volume":"374","author":"BT Hennessy","year":"2009","unstructured":"Hennessy, B.T., Coleman, R.L., Markman, M.: Ovarian cancer. Lancet 374, 1371\u20131382 (2009). \n                    https:\/\/doi.org\/10.1016\/S0140-6736(09)61338-6","journal-title":"Lancet"},{"key":"986_CR7","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ygyno.2009.11.033","volume":"117","author":"V Guarneri","year":"2010","unstructured":"Guarneri, V., Piacentini, F., Barbieri, E., Conte, P.F.: Achievements and unmet needs in the management of advanced ovarian cancer. Gynecol. Oncol. 117, 152\u2013158 (2010). \n                    https:\/\/doi.org\/10.1016\/j.ygyno.2009.11.033","journal-title":"Gynecol. Oncol."},{"key":"986_CR8","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ygyno.2014.04.013","volume":"133","author":"DG Mutch","year":"2014","unstructured":"Mutch, D.G., Prat, J.: 2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer. Gynecol. Oncol. 133, 401\u2013404 (2014). \n                    https:\/\/doi.org\/10.1016\/j.ygyno.2014.04.013","journal-title":"Gynecol. Oncol."},{"issue":"Supplement 1","key":"986_CR9","doi-asserted-by":"publisher","first-page":"S161","DOI":"10.1016\/S0020-7292(06)60033-7","volume":"95","author":"A Heintz","year":"2006","unstructured":"Heintz, A., Odicino, F., Maisonneuve, P., Quinn, M., Benedet, J., Creasman, W., Ngan, H., Pecorelli, S., Beller, U.: Carcinoma of the Ovary. Int. J. Gynecol. Obstet. 95(Supplement 1), S161\u2013S192 (2006). \n                    https:\/\/doi.org\/10.1016\/S0020-7292(06)60033-7","journal-title":"Int. J. Gynecol. Obstet."},{"key":"986_CR10","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.vhri.2014.07.002","volume":"4","author":"VI Ignatyeva","year":"2014","unstructured":"Ignatyeva, V.I., Derkach, E.V., Avxentyeva, M.V., Omelyanovsky, V.V.: The cost of melanoma and kidney, prostate, and ovarian cancers in Russia. Value Health Reg. Issues. 4, 58\u201365 (2014). \n                    https:\/\/doi.org\/10.1016\/j.vhri.2014.07.002","journal-title":"Value Health Reg. Issues."},{"key":"986_CR11","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.ygyno.2011.11.033","volume":"124","author":"G Bifulco","year":"2012","unstructured":"Bifulco, G., De Rosa, N., Tornesello, M.L., Piccoli, R., Bertrando, A., Lavitola, G., Morra, I., Sardo, A.D.S., Buonaguro, F.M., Nappi, C.: Quality of life, lifestyle behavior and employment experience: a comparison between young and midlife survivors of gynecology early stage cancers. Gynecol. Oncol. 124, 444\u2013451 (2012). \n                    https:\/\/doi.org\/10.1016\/j.ygyno.2011.11.033","journal-title":"Gynecol. Oncol."},{"key":"986_CR12","unstructured":"Sociedad Espa\u00f1ola de Ginecolog\u00eda y Obstetricia (SEGO): Oncogu\u00eda SEGO. C\u00e1ncer epitelial de ovario 2014. Gu\u00edas de pr\u00e1ctica cl\u00ednica en c\u00e1ncer ginecol\u00f3gico y mamario. (2014)"},{"key":"986_CR13","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/cncr.25490","volume":"117","author":"LR Boyd","year":"2011","unstructured":"Boyd, L.R., Novetsky, A.P., Curtin, J.P.: Ovarian cancer care for the underserved: are surgical patterns of care different in a public hospital setting? Cancer 117, 777\u2013783 (2011). \n                    https:\/\/doi.org\/10.1002\/cncr.25490","journal-title":"Cancer"},{"key":"986_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/NNR.0b013e3181ff77e4","volume":"60","author":"R McCorkle","year":"2011","unstructured":"McCorkle, R., Jeon, S., Ercolano, E., Schwartz, P.: Healthcare utilization in women after abdominal surgery for ovarian cancer. Nurs. Res. 60, 47\u201357 (2011). \n                    https:\/\/doi.org\/10.1097\/NNR.0b013e3181ff77e4","journal-title":"Nurs. Res."},{"key":"986_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ygyno.2012.06.033","volume":"127","author":"C Maringe","year":"2012","unstructured":"Maringe, C., Walters, S., Butler, J., Coleman, M.P., Hacker, N., Hanna, L., Mosgaard, B.J., Nordin, A., Rosen, B., Engholm, G., Gjerstorff, M.L., Hatcher, J., Johannesen, T.B., McGahan, C.E., Meechan, D., Middleton, R., Tracey, E., Turner, D., Richards, M.A., Rachet, B.: Stage at diagnosis and ovarian cancer survival: evidence from the international cancer benchmarking partnership. Gynecol. Oncol. 127, 75\u201382 (2012). \n                    https:\/\/doi.org\/10.1016\/j.ygyno.2012.06.033","journal-title":"Gynecol. Oncol."},{"key":"986_CR16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.rgmx.2013.01.005","volume":"78","author":"MT Vicente-Herrero","year":"2013","unstructured":"Vicente-Herrero, M.T., Terradillos-Garc\u00eda, M.J., Ramirez-I\u00f1iguez_de la Torre, M.V., Capdevila-Garc\u00eda, C., L\u00f3pez-Gonz\u00e1lez, L.M.: AA: Colorectal cancer in Spain: temporary disability and preventive occupational strategies. Rev. Gastroenterol. M\u00e9xico 78, 75\u201381 (2013). \n                    https:\/\/doi.org\/10.1016\/j.rgmx.2012.10.005","journal-title":"Rev. Gastroenterol. M\u00e9xico"},{"key":"986_CR17","doi-asserted-by":"publisher","first-page":"4362","DOI":"10.1002\/cncr.24588","volume":"115","author":"KR Yabroff","year":"2009","unstructured":"Yabroff, K.R., Kim, Y.: Time costs associated with informal caregiving for cancer survivors. Cancer. 115, 4362\u20134373 (2009). \n                    https:\/\/doi.org\/10.1002\/cncr.24588","journal-title":"Cancer."},{"key":"986_CR18","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1097\/IGC.0b013e318291e8ca","volume":"23","author":"K Kim","year":"2013","unstructured":"Kim, K., Hernlund, E., Hernadi, Z., R\u00e9v\u00e9sz, J., Pete, I., Sz\u00e1nth\u00f3, A., Bodnar, L., Madry, R., Timorek-Lemieszczuk, A., Bozanovic, T., Vasovic, S., Tomasevic, Z., Zivaljevic, M., Pazin, V., Min\u00e1rik, T., Garanov\u00e1, H., Helpianska, L., Justo, N.: Treatment patterns, health care utilization, and costs of ovarian cancer in Central and Eastern Europe using a Delphi panel based on a retrospective chart review. Int. J. Gynecol. Cancer Off. J. Int. Gynecol. Cancer Soc. 23, 823\u2013832 (2013). \n                    https:\/\/doi.org\/10.1097\/IGC.0b013e318291e8ca","journal-title":"Int. J. Gynecol. Cancer Off. J. Int. Gynecol. Cancer Soc."},{"key":"986_CR19","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1177\/0272989X9301300409","volume":"13","author":"FA Sonnenberg","year":"1993","unstructured":"Sonnenberg, F.A., Beck, J.R.: Markov models in medical decision making: a practical guide. Med. Decis. Making. 13, 322\u2013338 (1993). \n                    https:\/\/doi.org\/10.1177\/0272989X9301300409","journal-title":"Med. Decis. Making."},{"key":"986_CR20","unstructured":"Ovarian cancer incidence statistics, \n                    http:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/ovarian-cancer\/incidence"},{"key":"986_CR21","unstructured":"Instituto Nacional de Estad\u00edstica: Tasa de mortalidad. Tablas de mortalidad de la poblaci\u00f3n de Espa\u00f1a 1991\u20132016. Indicadores Demogr\u00e1ficos B\u00e1sicos (2016). \n                    http:\/\/www.ine.es\/jaxi\/menu.do?type=pcaxis&path=\/t20\/p319a\/&file=inebase"},{"key":"986_CR22","unstructured":"Resoluci\u00f3n de 30 de julio de 2012, de la Direcci\u00f3n de Gerencia del Servicio Aragon\u00e9s de Salud, sobre revisi\u00f3n de las tarifas a aplicar por la prestaci\u00f3n de servicios sanitarios a terceros obligados al pago o a usuarios sin derecho a asistencia sanitaria en la Comunidad Aut\u00f3noma de Arag\u00f3n. Bolet\u00edn Oficial de Arag\u00f3n n\u00fam. 156, 10 agosto de 2012 (2012)"},{"key":"986_CR23","unstructured":"Orden 731\/2013, de 6 de septiembre, del Consejero de Sanidad, por la que se fijan los precios p\u00fablicos por la prestaci\u00f3n de los servicios y actividades de naturaleza sanitaria de la Red de Centros de la Comunidad de Madrid. Bolet\u00edn Oficial de la Comunidad de Madrid n\u00fam. 215, 10 septiembre de 2013 (2013). \n                    http:\/\/w3.bocm.es\/boletin\/CM_Orden_BOCM\/2013\/09\/10\/BOCM-20130910-1.PDF"},{"key":"986_CR24","unstructured":"Resoluci\u00f3n de 30 de marzo de 2015, de la Directora, por la que se modifica la cuant\u00eda de los precios p\u00fablicos de servicios sanitarios previstos en el Decreto 81\/2009, de 16 de junio, que establece los precios p\u00fablicos de los servicios sanitarios prestados por el Servicio Canario de la Salud y fija sus cuant\u00edas. Bolet\u00edn Oficial de Canarias n\u00fam. 70, 14 abril de 2015 (2015)"},{"key":"986_CR25","unstructured":"Orden SAN\/12\/2011, de 20 de abril, por la que se fijan las cuant\u00edas de los precios p\u00fablicos de los Servicios Sanitarios prestados por el Servicio C\u00e1ntabro de Salud. Bolet\u00edn Oficial de Cantabria n\u00fam. 85, 5 de mayo de 2011 (2011). \n                    http:\/\/www.saludcantabria.es\/uploads\/pdf\/consejeria\/boletinesCVEordendeprecios.pdf"},{"key":"986_CR26","unstructured":"Resoluci\u00f3n del Director General del Servei de Salut de modificaci\u00f3n del anexo I de la Orden de la Conselleria de Salut i Consum de 22 de diciembre de 2006. Butllet\u00ed Oficial de les Illes Balears n\u00fam. 89, 1 de Julio de 2014 (2014). \n                    http:\/\/www.caib.es\/eboibfront\/es\/2014\/8339\/542720\/resolucion-del-director-general-del-servei-de-salu"},{"key":"986_CR27","unstructured":"Orden de 18 de noviembre de 2015, por la que se modifica la Orden de 14 de octubre de 2005, por la que se fijan los precios p\u00fablicos de los servicios sanitarios prestados por Centros dependientes del Sistema Sanitario P\u00fablico de Andaluc\u00eda (2015)"},{"key":"986_CR28","unstructured":"Resoluci\u00f3n 88\/2010, de 3 de mayo, del director gerente del Servicio Navarro de Salud-Osasunbidea. Por la que se actualizan las tarifas por prestaci\u00f3n de servicios en los centros y establecimientos asistenciales del Servicio Navarro de Salud-Osasunbidea n\u00fam. 71, 11 de junio de 2010 (2010)"},{"key":"986_CR29","unstructured":"Decreto 120\/2013, de 27 de diciembre, por lo que se actualizan los precios p\u00fablicos por cuant\u00eda fija. Bolet\u00edn Oficial del Principado de Asturias n\u00fam. 301 de 31 de diciembre de 2013 (2014)"},{"key":"986_CR30","unstructured":"Orden 17\/2014, de 16 de noviembre de 2014, de la Consejer\u00eda de Administraci\u00f3n P\u00fablica y Hacienda por la que se establece y regula el precio p\u00fablico por los servicios sanitarios prestados a particulares en los centros del Servicio Riojano de Salud. Bolet\u00edn Oficial de La Rioja n\u00fam. 156, 19 diciembre de 2014 (2014). \n                    http:\/\/ias1.larioja.org\/boletin\/Bor_Boletin_visor_Servlet?referencia=1902409-1-PDF-486979"},{"key":"986_CR31","unstructured":"Orden de 17\/11\/2014, de la Consejer\u00eda de Sanidad y Asuntos Sociales,por la que se establecen los precios p\u00fablicos de la asistencia sanitaria y de los servicios prestados en la red de centros sanitarios dependientes del Servicio de Salud de Castilla-La Mancha. Diario Oficial de Castilla-La Mancha n\u00fam. 226, 21 noviembre de 2014 (2014). \n                    http:\/\/docm.castillalamancha.es\/portaldocm\/descargarArchivo.do?ruta=2014\/11\/21\/pdf\/2014_15022.pdf&tipo=rutaDocm."},{"key":"986_CR32","unstructured":"Diario Oficial de la Generalitat Valenciana n\u00fam 970, de 31 de enero de 2014. Ley 5\/2013, de 23 de diciembre, de Medidas Fiscales, de Gesti\u00f3n Administrativa y Financiera, y de Organizaci\u00f3n de la Generalitat (2013). \n                    http:\/\/www.boe.es\/boe\/dias\/2014\/01\/31\/pdfs\/BOE-A-2014-970.pdf"},{"key":"986_CR33","unstructured":"Orden SLT\/30\/2013, de 20 de febrero, por la que se aprueban los precios p\u00fablicos del Servicio Catal\u00e1n de la Salud. Diario Oficial de la Generalitat de Catalunya n\u00fam. 6323, 26 febrero de 2013 (2013)"},{"key":"986_CR34","unstructured":"Decreto 56\/2014, de 30 de abril, por el que se establecen las tarifas de los servicios sanitarios prestados en los centros dependientes del Servicio Gallego de Salud y en las fundaciones p\u00fablicas sanitarias. Diario Oficial de Galicia n\u00fam. 96, 21 de mayo (2014)"},{"key":"986_CR35","unstructured":"Orden de 3 de febrero de 2015 de la Consejer\u00eda de Econom\u00eda y Hacienda,por la que se publican las tarifas de las tasas y precios p\u00fablicos aplicables en 2015. Bolet\u00edn Oficial de la Regi\u00f3n de Murcia n\u00fam. 33, 10 febrero de 2015 (2015). \n                    http:\/\/www.borm.es\/borm\/documento?obj=anu&id=725195"},{"key":"986_CR36","unstructured":"Bolet\u00edn Oficial del Estado (BOE) n\u00fam. 180. 29 de julio de 2013. Resoluci\u00f3n de 19 de julio de 2013, del Instituto Nacional de Gesti\u00f3n Sanitaria, sobre revisi\u00f3n de precios a aplicar por los centros sanitarios del Instituto Nacional de Gesti\u00f3n Sanitaria en Ceuta y Melilla, por las asistencias prestadas en los supuestos cuyo importe ha de reclamarse a los terceros obligados al pago o a los usuarios sin derecho a la asistencia sanitaria de la Seguridad Social, as\u00ed como por los servicios prestados por el Centro Nacional de Dosimetr\u00eda y por la reproducci\u00f3n de documentos de la biblioteca de la entidad gestora (2013)"},{"key":"986_CR37","unstructured":"Decreto 25\/2010, de 17 de junio, por el que se actualizan los precios p\u00fablicos por actos asistenciales y servicios sanitarios prestados por la Gerencia Regional de Salud de Castilla y Le\u00f3n. Bolet\u00edn Oficial de Castilla y Le\u00f3n n\u00fam. 119, 23 de junio de 2010 (2010)"},{"key":"986_CR38","unstructured":"Resoluci\u00f3n de 17 de febrero de 2015, del Consejero, por la que se publican las tarifas actualizadas de las tasas y precios p\u00fablicos de la Comunidad Aut\u00f3noma de Extremadura, en virtud de lo dispuesto en la Ley de Presupuestos Generales de la Comunidad Aut\u00f3noma de Extremadura para el 2015. Diario Oficial de Extremadura n\u00fam 36, 23 de febrero, 2015 (2015)"},{"key":"986_CR39","unstructured":"Acuerdo de 23 de febrero de 2015, del Consejo de administraci\u00f3n del ente p\u00fablico Osakidetza, por el que se aprueban las tarifas por prestaci\u00f3n de servicios sanitarios y docentes a terceros obligados al pago durante el ejercicio 2015 (2015). \n                    http:\/\/www.euskadi.eus\/contenidos\/informacion\/libro_tarifas\/es_libro\/adjuntos\/tarifas2015.pdf"},{"key":"986_CR40","unstructured":"Instituto Nacional de Estad\u00edstica (INE): Nivel y condiciones de vida (IPC)\/\u00cdndices de precios de consumo y vivienda\/\u00cdndice de precios de consumo\/\u00daltimos datos, \n                    http:\/\/www.ine.es\/dyngs\/INEbase\/es\/operacion.htm?c=Estadistica_C&cid=1254736176802&menu=ultiDatos&idp=1254735976607"},{"key":"986_CR41","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.gaceta.2009.07.011","volume":"24","author":"JL Bastida","year":"2010","unstructured":"Bastida, J.L., Oliva, J., Anto\u00f1anzas, F., Garc\u00eda-Alt\u00e9s, A., Gisbert, R., Mar, J., Puig-Junoy, J.: Propuesta de gu\u00eda para la evaluaci\u00f3n econ\u00f3mica aplicada a las tecnolog\u00edas sanitarias. Gac. Sanit. 24, 154\u2013170 (2010)","journal-title":"Gac. Sanit."},{"key":"986_CR42","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s10198-011-0344-9","volume":"13","author":"J Oliva-Moreno","year":"2012","unstructured":"Oliva-Moreno, J.: Loss of labour productivity caused by disease and health problems: what is the magnitude of its effect on Spain\u2019s Economy? Eur. J. Health Econ. HEPAC. 13, 605\u2013614 (2012). \n                    https:\/\/doi.org\/10.1007\/s10198-011-0344-9","journal-title":"Eur. J. Health Econ. HEPAC."},{"key":"986_CR43","unstructured":"Ag\u00e8ncia d\u2019Avaluaci\u00f3 de Tecnologia i Recerca M\u00e8diques (AATRM): Gu\u00eda de Pr\u00e1ctica cl\u00ednica. Oncogu\u00eda del Consejo y asesoramiento gen\u00e9ticos en el c\u00e1ncer hereditario. Versi\u00f3n completa. Ag\u00e8ncia d\u2019Avaluaci\u00f3 de Tecnologia i Recerca M\u00e8diques (AATRM) (2006)"},{"key":"986_CR44","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/ijc.20458","volume":"112","author":"J Balma\u00f1a","year":"2004","unstructured":"Balma\u00f1a, J., Sanz, J., Bonfill, X., Casado, A., Ru\u00e9, M., Gich, I., D\u00edez, O., Sabat\u00e9, J.M., Baiget, M., Alonso, M.C.: Genetic counseling program in familial breast cancer: analysis of its effectiveness, cost and cost-effectiveness ratio. Int. J. Cancer 112, 647\u2013652 (2004). \n                    https:\/\/doi.org\/10.1002\/ijc.20458","journal-title":"Int. J. Cancer"},{"key":"986_CR45","unstructured":"Drug shares. Quarter 3 data. Ipsos MORI Social Research Health, \n                    https:\/\/www.ipsos-mori.com\/researchspecialisms\/socialresearch\/specareas\/nhspublichealth.aspx"},{"key":"986_CR46","unstructured":"Bevacizumab. Avastin. Ficha T\u00e9cnica. European Medicines Agency (EMA) (2017). \n                    http:\/\/www.ema.europa.eu\/docs\/es_ES\/document_library\/EPAR_-_Product_Information\/human\/000582\/WC500029271.pdf"},{"key":"986_CR47","unstructured":"Carboplatino. Ficha T\u00e9cnica. Agencia Espa\u00f1ola del Medicamento (AEMPS) (2012). \n                    http:\/\/www.aemps.gob.es\/cima\/pdfs\/es\/ft\/70707\/FT_70707.pdf"},{"key":"986_CR48","unstructured":"Gemcitabina. Ficha T\u00e9cnica. Agencia Espa\u00f1ola del Medicamento (AEMPS) (2014). \n                    http:\/\/www.aemps.gob.es\/cima\/pdfs\/es\/ft\/76166\/FT_76166.pdf"},{"key":"986_CR49","unstructured":"Paclitaxel. Ficha T\u00e9cnica. Agencia Espa\u00f1ola del Medicamento (AEMPS) (2014). \n                    http:\/\/www.aemps.gob.es\/cima\/pdfs\/es\/ft\/73010\/FT_73010.pdf"},{"key":"986_CR50","unstructured":"Topotecan. Ficha T\u00e9cnica. Agencia Espa\u00f1ola del Medicamento (AEMPS) (2015). \n                    http:\/\/www.aemps.gob.es\/cima\/pdfs\/es\/ft\/72892\/FT_72892.pdf"},{"key":"986_CR51","unstructured":"Trabectedina. Yondelis. Ficha T\u00e9cnica. European Medicines Agency (EMA) (2012). \n                    http:\/\/www.ema.europa.eu\/docs\/es_ES\/document_library\/EPAR_-_Product_Information\/human\/000773\/WC500045832.pdf"},{"key":"986_CR52","unstructured":"Doxorubicina. Caelyx. Ficha T\u00e9cnica. Agencia Espa\u00f1ola del Medicamento (2006). \n                    http:\/\/www.ema.europa.eu\/docs\/es_ES\/document_library\/EPAR_-_Product_Information\/human\/000089\/WC500020180.pdf"},{"key":"986_CR53","unstructured":"Cisplatino. Ficha T\u00e9cnica. Agencia Espa\u00f1ola del Medicamento (AEMPS) (2014). \n                    http:\/\/www.aemps.gob.es\/cima\/pdfs\/es\/ft\/72609\/FT_72609.pdf"},{"key":"986_CR54","unstructured":"Docetaxel. Ficha T\u00e9cnica. Agencia Espa\u00f1ola del Medicamento (AEMPS) (2010). \n                    http:\/\/www.aemps.gob.es\/cima\/pdfs\/es\/ft\/74733\/FT_74733.pdf"},{"key":"986_CR55","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1200\/JCO.1989.7.11.1748","volume":"7","author":"AH Calvert","year":"1989","unstructured":"Calvert, A.H., Newell, D.R., Gumbrell, L.A., O\u2019Reilly, S., Burnell, M., Boxall, F.E., Siddik, Z.H., Judson, I.R., Gore, M.E., Wiltshaw, E.: Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 7, 1748\u20131756 (1989)","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"986_CR56","first-page":"303","volume":"5","author":"D Du Bois","year":"1989","unstructured":"Du Bois, D., Du Bois, E.F.: A formula to estimate the approximate surface area if height and weight be known. 1916. Nutr. Burbank Los Angel. Cty. Calif. 5, 303\u2013311 (1989) (discussion 312\u2013313)","journal-title":"Cty. Calif."},{"key":"986_CR57","unstructured":"Instituto Nacional de Estad\u00edstica: Microdatos de la encuesta nacional de salud (2012)"},{"key":"986_CR58","unstructured":"Consejo General de Colegios Oficiales de Farmac\u00e9uticos: Botplusweb.portalfarma.com. BOT Plus 2. Base de Datos de Medicamentos, \n                    https:\/\/botplusweb.portalfarma.com\/"},{"key":"986_CR59","unstructured":"Ministerio de Sanidad, Servicios Sociales e Igualdad. Listado de medicamentos afectados por el Real Decreto Ley 8\/2010, modificado por el Real Decreto Ley 9\/2011. \n                    http:\/\/www.msssi.gob.es\/profesionales\/farmacia\/notasInfor.htm"},{"key":"986_CR60","unstructured":"Ministerio de Sanidad Servicios Sociales e Igualdad: Informaci\u00f3n orientativa sobre los factores de conversi\u00f3n del PVL a PVP y PVP IVA, aplicables a partir de 1 de julio de 2010 (2010). \n                    http:\/\/www.msssi.gob.es\/profesionales\/farmacia\/pdf\/margenesFactoresConversion.pdf"},{"key":"986_CR61","unstructured":"Ministerio de Sanidad, Servicios Sociales e Igualdad: Factores de conversi\u00f3n de PVL a PVP y PVPiva julio 2010. RD-ley 4\/2010 de 26 de marzo - BOE 27 de marzo., \n                    http:\/\/www.msssi.gob.es\/profesionales\/farmacia\/notasInfor.htm"},{"key":"986_CR62","volume-title":"Estimaci\u00f3n del coste de administraci\u00f3n de Rituximab para el tratamiento de Linfomas No Hodgkin en hospitales de d\u00eda del SNS","author":"P Cabello","year":"2015","unstructured":"Cabello, P., Zozaya, N., Villoro, R., Hidalgo-Vega, \u00c1: Estimaci\u00f3n del coste de administraci\u00f3n de Rituximab para el tratamiento de Linfomas No Hodgkin en hospitales de d\u00eda del SNS. Presented at the las XXXV Jornadas de Econom\u00eda de la Salud, Granada (2015)"},{"key":"986_CR63","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1200\/JCO.2010.31.6752","volume":"29","author":"A Alonso-Babarro","year":"2011","unstructured":"Alonso-Babarro, A., Bruera, E., Varela-Cerdeira, M., Boya-Cristia, M.J., Madero, R., Torres-Vigil, I., De Castro, J., Gonzalez-Baron, M.: Can this patient be discharged home? Factors associated with at-home death among patients with cancer. J. Clin. Oncol. 29, 1159\u20131167 (2011). \n                    https:\/\/doi.org\/10.1200\/JCO.2010.31.6752","journal-title":"J. Clin. Oncol."},{"key":"986_CR64","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1177\/0269216312442973","volume":"27","author":"A Alonso-Babarro","year":"2013","unstructured":"Alonso-Babarro, A., Astray-Mochales, J., Dominguez-Berjon, F., Genova-Maleras, R., Bruera, E., Diaz-Mayordomo, A., Cortes, C.: C.: The association between in-patient death, utilization of hospital resources and availability of palliative home care for cancer patients. Palliat. Med. 27, 68\u201375 (2013). \n                    https:\/\/doi.org\/10.1177\/0269216312442973","journal-title":"Palliat. Med."},{"key":"986_CR65","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.jpainsymman.2010.02.026","volume":"40","author":"X G\u00f3mez-Batiste","year":"2010","unstructured":"G\u00f3mez-Batiste, X., Porta-Sales, J., Espinosa-Rojas, J., Pascual-L\u00f3pez, A., Tuca, A., Rodriguez, J.: Effectiveness of palliative care services in symptom control of patients with advanced terminal cancer: a Spanish, multicenter, prospective, quasi-experimental, pre-post study. J. Pain Symptom Manage. 40, 652\u2013660 (2010). \n                    https:\/\/doi.org\/10.1016\/j.jpainsymman.2010.02.026","journal-title":"J. Pain Symptom Manage."},{"key":"986_CR66","doi-asserted-by":"crossref","unstructured":"Calvo-Espinos, C., Ruiz de Gaona, E., Gonzalez, C., Ruiz de Galarreta, L., Lopez, C.: Palliative sedation for cancer patients included in a home care program: a retrospective study. Palliat. Support. Care. 1\u20136 (2014)","DOI":"10.1017\/S1478951514000200"},{"key":"986_CR67","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1177\/0269216309359996","volume":"24","author":"A Alonso-Babarro","year":"2010","unstructured":"Alonso-Babarro, A., Varela-Cerdeira, M., Torres-Vigil, I., Rodr\u00edguez-Barrientos, R., Bruera, E.: At-home palliative sedation for end-of-life cancer patients. Palliat. Med. 24, 486\u2013492 (2010). \n                    https:\/\/doi.org\/10.1177\/0269216309359996","journal-title":"Palliat. Med."},{"key":"986_CR68","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. Norwegian Institute of Public Health: WHOCC - ATC\/DDD Index, \n                    http:\/\/www.whocc.no\/atc_ddd_index\/"},{"key":"986_CR69","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1472-684X-13-45","volume":"13","author":"J Erlenwein","year":"2014","unstructured":"Erlenwein, J., Geyer, A., Schlink, J., Petzke, F., Nauck, F., Alt-Epping, B.: Characteristics of a palliative care consultation service with a focus on pain in a German university hospital. BMC Palliat. Care 13, 45 (2014). \n                    https:\/\/doi.org\/10.1186\/1472-684X-13-45","journal-title":"BMC Palliat. Care"},{"key":"986_CR70","unstructured":"Sociedad Espa\u00f1ola de Cuidados Paliativos (SECPAL): Gu\u00eda de Cuidados Paliativos. \n                    http:\/\/www.secpal.com\/%5C%5CDocumentos%5CPaginas%5Cguiacp.pdf"},{"key":"986_CR71","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1157\/13092768","volume":"127","author":"M Gonz\u00e1lez Bar\u00f3n","year":"2006","unstructured":"Gonz\u00e1lez Bar\u00f3n, M., G\u00f3mez Raposo, C., Vilches Aguirre, Y.: The last phase in the progressive neoplasic disease: care at the end-of-life, refractory symptoms and sedation. Med. Cl\u00edn. 127, 421\u2013428 (2006)","journal-title":"Med. Cl\u00edn."},{"key":"986_CR72","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4321\/S1135-57272015000200008","volume":"89","author":"M Ortega-Ortega","year":"2015","unstructured":"Ortega-Ortega, M., Montero-Granados, R., Romero-Aguilar, A.: Factores sociodemogr\u00e1ficos y cl\u00ednicos asociados a la recepci\u00f3n de cuidado informal en pacientes con neoplasia hematol\u00f3gica: estudio basado en las diferentes etapas del tratamiento. Rev. Esp. Salud P\u00fablica 89, 203\u2013215 (2015)","journal-title":"Rev. Esp. Salud P\u00fablica"},{"key":"986_CR73","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s10198-003-0189-y","volume":"5","author":"B Berg van den","year":"2004","unstructured":"van den Berg, B., Brouwer, W.B.F., Koopmanschap, M.A.: Economic valuation of informal care. Eur. J. Health Econ. Former. HEPAC. 5, 36\u201345 (2004). \n                    https:\/\/doi.org\/10.1007\/s10198-003-0189-y","journal-title":"Eur. J. Health Econ. Former. HEPAC."},{"key":"986_CR74","unstructured":"Ministerio de Sanidad, Servicios Sociales e Igualdad. Secretar\u00eda de Estado de Servicios Sociales e Igualdad. IMSERSO: Informe 2014. Las Personas Mayores en Espa\u00f1a. Datos estad\u00edsticos y Estatales y por Comunidades Aut\u00f3nomas (2015). \n                    http:\/\/www.imserso.es\/InterPresent1\/groups\/imserso\/documents\/binario\/22029_info2014pm.pdf"},{"key":"986_CR75","volume-title":"The demand for health: a theoretical and empirical investigation","author":"M Grossman","year":"1972","unstructured":"Grossman, M.: The demand for health: a theoretical and empirical investigation. Columbia Univ. Press [u.a.], New York, NY (1972)"},{"key":"986_CR76","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s10198-011-0344-9","volume":"13","author":"J Oliva-Moreno","year":"2012","unstructured":"Oliva-Moreno, J.: Loss of labour productivity caused by disease and health problems: what is the magnitude of its effect on Spain\u2019s Economy? Eur. J. Health Econ. 13, 605\u2013614 (2012). \n                    https:\/\/doi.org\/10.1007\/s10198-011-0344-9","journal-title":"Eur. J. Health Econ."},{"key":"986_CR77","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1086\/258535","volume":"69","author":"BA Weisbrod","year":"1961","unstructured":"Weisbrod, B.A.: The Valuation of Human Capital. J. Polit. Econ. 69, 425\u2013436 (1961)","journal-title":"J. Polit. Econ."},{"key":"986_CR78","doi-asserted-by":"publisher","first-page":"i89","DOI":"10.1136\/ard.2009.117150","volume":"69","author":"WB Hout van","year":"2010","unstructured":"van Hout, W.B.: den: The value of productivity: human-capital versus friction-cost method. Ann. Rheum. Dis. 69, i89\u2013i91 (2010). \n                    https:\/\/doi.org\/10.1136\/ard.2009.117150","journal-title":"Ann. Rheum. Dis."},{"key":"986_CR79","unstructured":"Instituto Nacional de Estad\u00edstica: Media de los cuatro trimestres del a\u00f1o. Activos por sexo y grupo de edad. Valores absolutos y porcentajes respecto del total de cada sexo. \n                    http:\/\/www.ine.es\/jaxiT3\/Tabla.htm?t=4731&L=0"},{"key":"986_CR80","unstructured":"Instituto Nacional de Estad\u00edstica: Resultados Nacionales: Ganancia media anual por trabajador. Encuesta anual de estructura salarial. Serie 2008\u20132013. \n                    http:\/\/www.ine.es\/jaxiT3\/Tabla.htm?path=\/t22\/p133\/cno11\/serie\/l0\/&file=02005.px&L=0"},{"key":"986_CR81","unstructured":"Seguridad Social: Trabajadores. Prestaciones\/Pensiones de Trabajadores. Incapacidad temporal. R\u00e9gimen General. Nacimiento del derecho\/Duraci\u00f3n\/P\u00e9rdida o suspensi\u00f3n\/Extinci\u00f3n. \n                    http:\/\/www.seg-social.es\/Internet_1\/Trabajadores\/PrestacionesPension10935\/Incapacidadtemporal\/RegimenGeneral\/Nacimientodelderech28368\/6394"},{"key":"986_CR82","unstructured":"Instituto Nacional de Estad\u00edstica: Estad\u00edstica del Padr\u00f3n Continuo. Datos provisionales a 1 de enero de 2016. Mujeres. \n                    http:\/\/www.ine.es\/jaxi\/Datos.htm?path=\/t20\/e245\/p04\/provi\/l0\/&file=00000002.px"},{"key":"986_CR83","unstructured":"Instituto Nacional de Estad\u00edstica: Resultados Nacionales: Ganancia media anual por trabajador seg\u00fan sexo y edad. Encuesta anual de estructura salarial. Serie 2008\u20132014 (2014). \n                    http:\/\/www.ine.es\/jaxi\/Datos.htm?path=\/t22\/p133\/cno11\/serie\/l0\/&file=02005.px"},{"key":"986_CR84","unstructured":"Instituto Nacional de Estad\u00edstica: Encuesta de estructural salarial. A\u00f1o 2014. Ganancia media por hora por trabajador: Trabajadores de los servicios de restauraci\u00f3n, personales, protecci\u00f3n y vendedores. \n                    http:\/\/www.ine.es\/jaxi\/Datos.htm?path=\/t22\/p133\/a2014\/l0\/&file=09002.px"},{"key":"986_CR85","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s40273-014-0218-y","volume":"33","author":"M Krol","year":"2015","unstructured":"Krol, M., Papenburg, J., van Exel, J.: Does including informal care in economic evaluations matter? A systematic review of inclusion and impact of informal care in cost-effectiveness studies. PharmacoEconomics. 33, 123\u2013135 (2015). \n                    https:\/\/doi.org\/10.1007\/s40273-014-0218-y","journal-title":"PharmacoEconomics."},{"key":"986_CR86","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.jval.2012.05.009","volume":"15","author":"K Goodrich","year":"2012","unstructured":"Goodrich, K., Kaambwa, B., Al-Janabi, H.: The inclusion of informal care in applied economic evaluation: a review. Value Health J. Int. Soc. Pharmacoeconomics Outcomes Res. 15, 975\u2013981 (2012). \n                    https:\/\/doi.org\/10.1016\/j.jval.2012.05.009","journal-title":"Value Health J. Int. Soc. Pharmacoeconomics Outcomes Res."},{"key":"986_CR87","unstructured":"Ministerio de Sanidad, Servicios Sociales e Igualdad. Instituto de Informaci\u00f3n Sanitaria. Registro de altas\u2014CMBD. CIE9: 183 (2014). \n                    http:\/\/pestadistico.inteligenciadegestion.msssi.es\/publicosns"},{"key":"986_CR88","unstructured":"Ministerio de Sanidad, Servicios Sociales e Igualdad. Instituto de Informaci\u00f3n Sanitaria. Registro de altas\u2014CMBD. CIE9: 183. Unidad de cuidados paliativos (2014). \n                    http:\/\/pestadistico.inteligenciadegestion.msssi.es\/publicosns"},{"key":"986_CR89","unstructured":"Instituto de Mayores y Servicios Sociales (IMSERSO): INFORME 2014. Las personas Mayores en Espa\u00f1a. Datos Estad\u00edsticos Estatales y por Comunidades Aut\u00f3nomas (2014). \n                    http:\/\/www.imserso.es\/InterPresent1\/groups\/imserso\/documents\/binario\/22029_info2014pm.pdf"}],"container-title":["The European Journal of Health Economics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10198-018-0986-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-018-0986-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-018-0986-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T17:09:20Z","timestamp":1567098560000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10198-018-0986-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,19]]},"references-count":89,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["986"],"URL":"https:\/\/doi.org\/10.1007\/s10198-018-0986-y","relation":{},"ISSN":["1618-7598","1618-7601"],"issn-type":[{"value":"1618-7598","type":"print"},{"value":"1618-7601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,19]]},"assertion":[{"value":"22 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study was funded by AstraZeneca (AstraZeneca Farmac\u00e9utica Spain S.A.), although AstraZeneca did not influence on the results of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Authors Laura Delgado-Ortega, Luis Cordero, Susana Simon and Carlota Moya-Alarc\u00f3n are employees of AstraZeneca. Authors Almudena Gonz\u00e1lez-Dom\u00ednguez and Margarita Jim\u00e9nez work in Weber, enterprise that received fees from AstraZeneca. Authors Josep Mar\u00eda Borr\u00e1s, Juan Oliva-Moreno, Eva Gonz\u00e1lez-Haba, Salom\u00f3n Menj\u00f3n, Pedro P\u00e9rez and David Vicente have received honorarium from AstraZeneca Spain, during the conduct of the study. Author \u00c1lvaro Hidalgo-Vega has no potential conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}